Research Report Details
Subscribe for industry reports
Author / Researcher : Technavio
Number Of Pages/Tabs : 70
Number Of Charts : N/A
Published Date : 08/26/2015
Industries : Healthcare and Medical Devices
Countries : All
Quality Score : 5
Have a question about this report?
24/7 Research Support
Talk to Zursh Analyst
+1 858 522 9998 or Email Us
This syndrome is of two types: aqueous tear deficient dry eye and evaporative dry eye. In aqueous tear deficient dry eye, lacrimal glands do not produce enough tears, whereas meibomian gland dysfunction results in evaporative dry eye.
Meibomian glands secrete lipids to slow tear evaporation and maintain tear stability. The symptoms include pain, redness, burning, and fatigue in the eye and decreased tolerance to continuous visual activity.
Dry eye syndrome cannot be cured, but symptoms can be controlled. Teardrops and anti-inflammatory drugs are used in the treatment.
Technavio's analysts forecast the global dry eye syndrome market to grow at a CAGR of 4.75% over the period 2014-2019. Covered in this report The report includes the present scenario and the growth prospects of the global dry eye syndrome market for the period 2015-2019.
To calculate the market size, the report considers revenue generated from the sales of teardrops and anti-inflammatory drugs used in the treatment of dry eye syndrome.
Technavio's report, Global Dry Eye Syndrome Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.
It covers the market size and forecast as well as market segmentation. The report includes a discussion of the key vendors operating in this market. Key regions • Americas • APAC • EMEA Key vendors • Alcon • Allergan • Otsuka Holdings • Santen Pharmaceuticals Other prominent vendors • Acadia Pharmaceuticals • Aciex • Allostera Pharma • arGentis • Auven Therapeutics (Celtic) • Bridge Pharma • Can-Fite • Cellzome Key market driver • Growing prevalence of dry eye syndrome • For a full, detailed list, view our report Key market challenge • Self-medication by patients • For a full, detailed list, view our report Key market trend • Growing awareness about the syndrome • For a full, detailed list, view our report Key questions answered in this report • What will the market size be in 2019 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors?.
PART 01: Executive summary Highlights PART 02: Scope of the report Market overview Top-vendor offerings PART 03: Market research methodology Research methodology Economic indicators PART 04: Introduction Key market highlights PART 05: Disease overview Understanding dry eye syndrome Types of dry eye syndrome Risk factors for dry eye syndrome Signs and symptoms Causes of dry eye syndrome Epidemiology Diagnosis Disease management PART 06: Market landscape Market overview Market size and forecast Five forces analysis PART 07: Pipeline analysis Cyclokat Diquas EBI-005 MIM-D3 Lifitegrast RGN-259 EBI-005 EGP-437 PART 08: Market segmentation by sub-type of dry eye PART 09: Market segmentation by drug type Oral antibiotics Eye drops Eye inserts Eye ointments PART 10: Geographical segmentation Market drivers PART 11: Impact of drivers PART 12: Market challenges PART 13: Impact of drivers and challenges PART 14: Market trends PART 15: Vendor landscape Competitive scenario Market share analysis 2014 Other prominent vendors PART 16: Key vendor analysis Alcon Allergan Otsuka Holdings Santen Pharmaceuticals PART 17: Appendix List of abbreviations PART 18: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Regional prevalence of dry eye syndrome Exhibit 03: Diagnosis of dry eye syndrome Exhibit 04: Surgical options Exhibit 05: Punctal plugs Exhibit 06: Global dry eye syndrome market 2014-2019 ($ billions) Exhibit 07: Five forces analysis Exhibit 08: Market segmentation by sub-type of dry eye Exhibit 09: Dry eye syndrome: pharmacologic therapy Exhibit 10: Artificial tears: Different generations Exhibit 11: Global dry eye syndrome market share 2014 Exhibit 12: Global dry eye syndrome: Key drivers Exhibit 13: Impact of drivers Exhibit 14: Global dry eye syndrome: Key challenges Exhibit 15: Impact of drivers and challenges Exhibit 16: Global dry eye syndrome: Emerging trends Exhibit 17: Global dry eye syndrome market share analysis 2014 Exhibit 18: Alcon: Business strategy Exhibit 19: Alcon: Distribution of sales by category 2014 Exhibit 20: Alcon: Region-wise sales distribution 2014 ($ millions) Exhibit 21: Alcon: Region-wise sales distribution 2013 ($ millions) Exhibit 22: Systane: Global sales 2011-2014 ($ millions) Exhibit 23: Allergan: Business strategy Exhibit 24: Eye care pharmaceuticals: Global sales 2011-2014 ($ millions) Exhibit 25: Restasis: Global sales 2011-2014 ($ millions) Exhibit 26: Santen Pharmaceuticals: Business strategy Exhibit 27: Hyalein: Global sales 2011-2014 ($ millions) Exhibit 28: Diquas: Global sales 2011-2014 ($ millions) Exhibit 29: Prescription ophthalmics : Global sales 2011-2014 ($ millions) Exhibit 30: Alcon: Business segmentation 2014 Exhibit 31: Allergan: Business segmentation by revenue 2014 Exhibit 32: Allergan: Business segmentation by revenue 2013 and 2014 ($ millions) Exhibit 33: Allergan: Geographical segmentation by revenue 2014 Exhibit 34: Santen Pharmaceutical: Business/Product segmentation 2014 by revenue
Summary of Source & MethodologyTrue
Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.
Download additional documents & original sources used by researcher/publisher to support the report dataDownload Documents No documents available for download
Zursh quality control analysts have developed a nice rating algorithm to independently and objectively evaluate the quality of this report.
Technavio models the market trends using a mix of quantitative and qualitative tools in its proprietary research methodologies. Their team of over 300 specialized analysts continuously monitors and evaluates the market landscape and builds forecasts across market segments and geographical regions based on the trends identified.
Founded in 2003 and headquartered in London, UK, Technavio has offices across North America, Europe, and Asia. Covering more than 100 industries across 50 countries, they develop over 5,000 research deliverables every year.